Pfizer's new vaccine R&D leader Anderson has a high bar to reach in replacing Jansen

As Pfizer’s new VP and head of the company’s vaccine research and development, Annaliesa Anderson, Ph.D., has a tough act to follow.

Anderson will replace retiring Kathrin Jansen, who climaxed her career with a brilliant swan song—leading Pfizer’s collaboration with BioNTech which produced the world’s most successful COVID-19 vaccine.